Meriwether Wealth & Planning’s Royalty Pharma RPRX Stock Holding History

Meriwether Wealth & Planning’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$17.1K	Buy	+293	New	+$17.3K	0.01%	357

Other funds holding RPRX

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Daiwa Securities Group Tokyo, Japan $53.6B AUM 32.29% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return

Fideuram Asset Management (Ireland) Dublin 1 $4.57B AUM 30.36% 1-Year Est. Return

Todd Asset Management Louisville, Kentucky $5.51B AUM 33.77% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return

Meriwether Wealth & Planning's RPRX Position: Q3 2026 in Review

Meriwether Wealth & Planning opened a new position in Royalty Pharma (RPRX) in Q3 2026: 293 shares worth $17.1K. The stake represents 0.01% of the portfolio and ranks #357 among its holdings.

186 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

Meriwether Wealth & Planning held 293 shares of Royalty Pharma worth $17.1K as of Q3 2026.
Royalty Pharma was a new Meriwether Wealth & Planning position in Q3 2026.
Royalty Pharma made up 0.01% of Meriwether Wealth & Planning's portfolio in Q3 2026, its #357 holding.
186 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on Meriwether Wealth & Planning's 13F filing for Q3 2026, filed 13 Oct 2026.